Primary infection by a human immunodeficiency virus with atypical coreceptor tropism

Journal of Virology

Volumn 85, Issue 20, 2011, Pages 10669-10681

  Jiang, Chunlai ^a,d   Parrish, Nicholas F ^b   Wilen, Craig B ^b   Li, Hui ^b   Chen, Yue ^a   Pavlicek, Jeffrey W ^a   Berg, Anna ^a   Lu, Xiaozhi ^a   Song, Hongshuo ^a   Tilton, John C ^b,e   Pfaff, Jennifer M ^b   Henning, Elizabeth A ^b   Decker, Julie M ^b   Moody, M Anthony ^a   Drinker, Mark S ^a   Schutte, Robert ^a   Freel, Stephanie ^a   Tomaras, Georgia D ^a   Nedellec, Rebecca ^c   Mosier, Donald E ^c   Haynes, Barton F ^a   Shaw, George M ^b   Hahn, Beatrice H ^b   Doms, Robert W ^b   Gao, Feng ^a   more..

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

^c SCRIPPS RESEARCH INSTITUTE   (United States)

^d JILIN UNIVERSITY   (China)

^e CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

APELIN RECEPTOR; CD4 ANTIGEN; CHEMOKINE RECEPTOR CCR5; CHEMOKINE RECEPTOR CXCR4; FORMYLPEPTIDE RECEPTOR LIKE 1; G PROTEIN COUPLED RECEPTOR; G PROTEIN COUPLED RECEPTOR 15; UNCLASSIFIED DRUG; VIRUS ENVELOPE PROTEIN; VIRUS RNA;

AMINO ACID SEQUENCE; ARTICLE; BLOOD SAMPLING; CD4+ T LYMPHOCYTE; CLADISTICS; CONSENSUS SEQUENCE; CONTROLLED STUDY; GENE MUTATION; GENE OVEREXPRESSION; HOMOZYGOSITY; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION; IN VITRO STUDY; MACROPHAGE; MOLECULAR CLONING; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN CONFORMATION; PROTEIN MOTIF; RECEPTOR UPREGULATION; VIRAL TROPISM; VIRUS CELL INTERACTION; VIRUS ENVELOPE; VIRUS REPLICATION; VIRUS STRAIN;

AMINO ACID MOTIFS; AMINO ACID SUBSTITUTION; CD4-POSITIVE T-LYMPHOCYTES; CELLS, CULTURED; ENV GENE PRODUCTS, HUMAN IMMUNODEFICIENCY VIRUS; GENE EXPRESSION; HIV-1; HUMANS; MACROPHAGES; RECEPTORS, FORMYL PEPTIDE; RECEPTORS, G-PROTEIN-COUPLED; RECEPTORS, HIV; RECEPTORS, LIPOXIN; RECEPTORS, PEPTIDE; VIRAL TROPISM;

CERCOPITHECINE HERPESVIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1;

EID: 80055021610     PISSN: 0022538X     EISSN: 10985514     Source Type: Journal    
DOI: 10.1128/JVI.05249-11     Document Type: Article

References (67)

1. Abrahams, M. R., et al. 2009. Quantitating the multiplicity of infection with human immunodeficiency virus type 1 subtype C reveals a non-Poisson distribution of transmitted variants. J. Virol. 83:3556-3567.
2. Baba, M., H. Miyake, X. Wang, M. Okamoto, and K. Takashima. 2007. Isolation and characterization of human immunodeficiency virus type 1 resistant to the small-molecule CCR5 antagonist TAK-652. Antimicrob. Agents Chemother. 51:707-715.
3. Begaud, E., et al. 2003. Broad spectrum of coreceptor usage and rapid disease progression in HIV-1-infected individuals from Central African Republic. AIDS Res. Hum. Retroviruses 19:551-560.
4. Berger, E. A., P. M. Murphy, and J. M. Farber. 1999. Chemokine receptors as HIV-1 coreceptors: roles in viral entry, tropism, and disease. Annu. Rev. Immunol. 17:657-700.
5. Berro, R., et al. 2011. Multiple CCR5 conformations on the cell surface are used differentially by human immunodeficiency viruses resistant or sensitive to CCR5 inhibitors. J. Virol. 85:8227-8240.
6. Berro, R., R. W. Sanders, M. Lu, P. J. Klasse, and J. P. Moore. 2009. Two HIV-1 variants resistant to small molecule CCR5 inhibitors differ in how they use CCR5 for entry. PLoS Pathog. 5:e1000548.
7. Cai, F., et al. 2007. Detection of minor drug-resistant populations by parallel allele-specific sequencing. Nat. Methods 4:123-125.
8. Chen, Z., et al. 1998. Natural infection of a homozygous delta24 CCR5 red-capped mangabey with an R2b-tropic simian immunodeficiency virus. J. Exp. Med. 188:2057-2065.
9. Choe, H., et al. 1998. The orphan seven-transmembrane receptor apj supports the entry of primary T-cell-line-tropic and dualtropic human immunodeficiency virus type 1. J. Virol. 72:6113-6118.
10. Cilliers, T., et al. 2003. The CCR5 and CXCR4 coreceptors are both used by human immunodeficiency virus type 1 primary isolates from subtype C. J. Virol. 77:4449-4456.
11. Cilliers, T., et al. 2005. Use of alternate coreceptors on primary cells by two HIV-1 isolates. Virology 339:136-144.
12. Clayton, F., et al. 2001. Gp120-induced Bob/GPR15 activation: a possible cause of human immunodeficiency virus enteropathy. Am. J. Pathol. 159: 1933-1939.
13. Cormier, E. G., and T. Dragic. 2002. The crown and stem of the V3 loop play distinct roles in human immunodeficiency virus type 1 envelope glycoprotein interactions with the CCR5 coreceptor. J. Virol. 76:8953-8957.
14. Cormier, E. G., D. N. Tran, L. Yukhayeva, W. C. Olson, and T. Dragic. 2001. Mapping the determinants of the CCR5 amino-terminal sulfopeptide interaction with soluble human immunodeficiency virus type 1 gp120-CD4 complexes. J. Virol. 75:5541-5549.
15. Deng, H. K., D. Unutmaz, V. N. KewalRamani, and D. R. Littman. 1997. Expression cloning of new receptors used by simian and human immunodeficiency viruses. Nature 388:296-300.
16. Doranz, B. J., et al. 1997. Two distinct CCR5 domains can mediate coreceptor usage by human immunodeficiency virus type 1. J. Virol. 71:6305-6314.
17. Dragic, T., et al. 2000. A binding pocket for a small molecule inhibitor of HIV-1 entry within the transmembrane helices of CCR5. Proc. Natl. Acad. Sci. U. S. A. 97:5639-5644.
18. Edinger, A. L., et al. 1998. An orphan seven-transmembrane domain receptor expressed widely in the brain functions as a coreceptor for human immunodeficiency virus type 1 and simian immunodeficiency virus. J. Virol. 72:7934-7940.
19. Farzan, M., et al. 1997. Two orphan seven-transmembrane segment receptors which are expressed in CD4-positive cells support simian immunodeficiency virus infection. J. Exp. Med. 186:405-411.
20. Faulkner, D. V., and J. Jurka. 1988. Multiple aligned sequence editor (MASE). Trends Biochem. Sci. 13:321-322.
21. Fiebig, E. W., et al. 2003. Dynamics of HIV viremia and antibody seroconversion in plasma donors: implications for diagnosis and staging of primary HIV infection. AIDS 17:1871-1879.
22. Gnanadurai, C. W., et al. 2010. Genetic identity and biological phenotype of a transmitted/founder virus representative of nonpathogenic simian immunodeficiency virus infection in African green monkeys. J. Virol. 84:12245-12254.
23. Goodenow, M. M., and R. G. Collman. 2006. HIV-1 coreceptor preference is distinct from target cell tropism: a dual-parameter nomenclature to define viral phenotypes. J. Leukoc. Biol. 80:965-972.
24. Gorry, P. R., et al. 2002. Persistence of dual-tropic HIV-1 in an individual homozygous for the CCR5 Delta 32 allele. Lancet 359:1832-1834.
25. Huang, C. C., et al. 2005. Structure of a V3-containing HIV-1 gp120 core. Science 310:1025-1028.
26. Isaacman-Beck, J., et al. 2009. Heterosexual transmission of human immunodeficiency virus type 1 subtype C: macrophage tropism, alternative coreceptor use, and the molecular anatomy of CCR5 utilization. J. Virol. 83: 8208-8220.
27. Johnston, S. H., et al. 2009. A quantitative affinity-profiling system that reveals distinct CD4/CCR5 usage patterns among human immunodeficiency virus type 1 and simian immunodeficiency virus strains. J. Virol. 83:11016-11026.
28. Keele, B. F., et al. 2008. Identification and characterization of transmitted and early founder virus envelopes in primary HIV-1 infection. Proc. Natl. Acad. Sci. U. S. A. 105:7552-7557.
29. Keele, B. F., et al. 2009. Low-dose rectal inoculation of rhesus macaques by SIVsmE660 or SIVmac251 recapitulates human mucosal infection by HIV-1. J. Exp. Med. 206:1117-1134.
30. Kimura, M. 1980. A simple method for estimating evolutionary rates of base substitutions through comparative studies of nucleotide sequences. J. Mol. Evol. 16:111-120.
31. Kirchherr, J. L., et al. 2011. Identification of amino acid substitutions associated with neutralization phenotype in the human immunodeficiency virus type-1 subtype C gp120. Virology 409:163-174.
32. Kirchherr, J. L., et al. 2007. High throughput functional analysis of HIV-1 env genes without cloning. J. Virol. Methods 143:104-111.
33. Kondru, R., et al. 2008. Molecular interactions of CCR5 with major classes of small-molecule anti-HIV CCR5 antagonists. Mol. Pharmacol. 73:789-800.
34. Kraus, M. H., et al. 2010. A rev1-vpu polymorphism unique to HIV-1 subtype A and C strains impairs envelope glycoprotein expression from rev-vpu-env cassettes and reduces virion infectivity in pseudotyping assays. Virology 397:346-357.
35. Laakso, M. M., et al. 2007. V3 loop truncations in HIV-1 envelope impart resistance to coreceptor inhibitors and enhanced sensitivity to neutralizing antibodies. PLoS Pathog. 3:e117.
36. Lee, B., et al. 1999. Epitope mapping of CCR5 reveals multiple conformational states and distinct but overlapping structures involved in chemokine and coreceptor function. J. Biol. Chem. 274:9617-9626.
37. Lee, H. Y., et al. 2009. Modeling sequence evolution in acute HIV-1 infection. J. Theor. Biol. 261:341-360.
38. Li, H., et al. 2010. High multiplicity infection by HIV-1 in men who have sex with men. PLoS Pathog. 6:e1000890.
39. Liu, J., et al. 2011. Analysis of low frequency mutations associated with drug-resistance to raltegravir before antiretroviral treatment. Antimicrob. Agents Chemother. 55:1114-1119.
40. Lu, X., B. Hora, F. Cai, and F. Gao. 2010. Generation of random mutant libraries with multiple primers in a single reaction. J. Virol. Methods 167: 146-151.
41. Michael, N. L., et al. 1998. Exclusive and persistent use of the entry coreceptor CXCR4 by human immunodeficiency virus type 1 from a subject homozygous for CCR5 delta32. J. Virol. 72:6040-6047.
42. Migeotte, I., D. Communi, and M. Parmentier. 2006. Formyl peptide receptors: a promiscuous subfamily of G protein-coupled receptors controlling immune responses. Cytokine Growth Factor Rev. 17:501-519.
43. Nedellec, R., et al. 2009. Virus entry via the alternative coreceptors CCR3 and FPRL1 differs by human immunodeficiency virus type 1 subtype. J. Virol. 83:8353-8363.
44. O'Brien, T. R., et al. 1997. HIV-1 infection in a man homozygous for CCR5 delta 32. Lancet 349:1219.
45. Ogert, R. A., et al. 2008. Mapping resistance to the CCR5 co-receptor antagonist vicriviroc using heterologous chimeric HIV-1 envelope genes reveals key determinants in the C2-V5 domain of gp120. Virology 373:387-399.
46. + T cells. J. Virol. 84:6505-6514.
47. Pohlmann, S., M. Krumbiegel, and F. Kirchhoff. 1999. Coreceptor usage of BOB/GPR15 and Bonzo/STRL33 by primary isolates of human immunodeficiency virus type 1. J. Gen. Virol. 80:1241-1251.
48. Quinonez, R., I. Sinha, I. R. Singh, and R. E. Sutton. 2003. Genetic footprinting of the HIV co-receptor CCR5: delineation of surface expression and viral entry determinants. Virology 307:98-115.
49. Riddick, N. E., et al. 2010. A novel CCR5 mutation common in sooty mangabeys reveals SIVsmm infection of CCR5-null natural hosts and efficient alternative coreceptor use in vivo. PLoS Pathog. 6:e1001064.
50. Rizzuto, C., and J. Sodroski. 2000. Fine definition of a conserved CCR5-binding region on the human immunodeficiency virus type 1 glycoprotein 120. AIDS Res. Hum. Retroviruses 16:741-749.
51. Rizzuto, C. D., et al. 1998. A conserved HIV gp120 glycoprotein structure involved in chemokine receptor binding. Science 280:1949-1953.
52. Saitou, N., and M. Nei. 1987. The neighbor-joining method: a new method for reconstructing phylogenetic trees. Mol. Biol. Evol. 4:406-425.
53. Salazar-Gonzalez, J. F., et al. 2008. Deciphering human immunodeficiency virus type 1 transmission and early envelope diversification by single-genome amplification and sequencing. J. Virol. 82:3952-3970.
54. Salazar-Gonzalez, J. F., et al. 2009. Genetic identity, biological phenotype, and evolutionary pathways of transmitted/founder viruses in acute and early HIV-1 infection. J. Exp. Med. 206:1273-1289.
55. Seibert, C., et al. 2006. Interaction of small molecule inhibitors of HIV-1 entry with CCR5. Virology 349:41-54.
56. Sharron, M., et al. 2000. Expression and coreceptor activity of STRL33/ Bonzo on primary peripheral blood lymphocytes. Blood 96:41-49.
57. Shimizu, N., et al. 2009. Broad usage spectrum of G protein-coupled receptors as coreceptors by primary isolates of HIV. AIDS 23:761-769.
58. Stone, M., et al. 2010. A limited number of SIVenv variants are transmitted to rhesus macaques vaginally inoculated with SIVmac251. J. Virol. 84:7083-7095.
59. Takehisa, J., et al. 2009. Origin and biology of simian immunodeficiency virus in wild-living western gorillas. J. Virol. 83:1635-1648.
60. Thompson, J. D., D. G. Higgins, and T. J. Gibson. 1994. CLUSTAL W: improving the sensitivity of progressive multiple sequence alignment through sequence weighting, position-specific gap penalties and weight matrix choice. Nucleic Acids Res. 22:4673-4680.
61. Tilton, J. C., et al. 2010. A maraviroc-resistant HIV-1 with narrow crossresistance to other CCR5 antagonists depends on both N-terminal and extracellular loop domains of drug-bound CCR5. J. Virol. 84:10863-10876.
62. Trkola, A., et al. 2001. Potent, broad-spectrum inhibition of human immunodeficiency virus type 1 by the CCR5 monoclonal antibody PRO 140. J. Virol. 75:579-588.
63. Tsibris, A. M., et al. 2008. In vivo emergence of vicriviroc resistance in a human immunodeficiency virus type 1 subtype C-infected subject. J. Virol. 82:8210-8214.
64. Wilen, C. B., et al. 2011. Phenotypic and immunologic comparison of clade B transmitted/founder and chronic HIV-1 envelope glycoproteins. J. Virol. 85:8514-8527.
65. Xiang, S. H., et al. 2005. Functional mimicry of a human immunodeficiency virus type 1 coreceptor by a neutralizing monoclonal antibody. J. Virol. 79:6068-6077.
66. Xiao, L., D. L. Rudolph, S. M. Owen, T. J. Spira, and R. B. Lal. 1998. Adaptation to promiscuous usage of CC and CXC-chemokine coreceptors in vivo correlates with HIV-1 disease progression. AIDS 12:F137-143.
67. Yeh, W. W., et al. 2010. Autologous neutralizing antibodies to the transmitted/ founder viruses emerge late after simian immunodeficiency virus SIVmac251 infection of rhesus monkeys. J. Virol. 84:6018-6032.